Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments in purging in autotransplantation

A S Freedman1, L M Nadler

  • 1Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Hematology/Oncology Clinics of North America
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia.

Leukemia & lymphoma·2015
Same author

Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Germline copy number variation associated with Mendelian inheritance of CLL in two families.

Leukemia·2012
Same author

(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.

Bone marrow transplantation·2011
Same author

A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.

Leukemia·2010

High-dose therapy with autologous bone marrow transplantation (BMT) for hematologic malignancies faces challenges with residual tumor cells. Ex vivo purging techniques show promise in improving disease-free survival, though further randomized trials are needed.

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • High-dose therapy and bone marrow transplantation (BMT) offer curative potential for hematologic malignancies.
  • Challenges include donor availability, graft-versus-host disease, and interstitial pneumonitis.
  • Autologous BMT reduces toxicity but risks reinfusing residual tumor cells.

Purpose of the Study:

  • To review the efficacy of ex vivo marrow purging techniques in eliminating residual tumor cells.
  • To explore the impact of ex vivo purging on disease-free survival in patients undergoing high-dose therapy and BMT.

Main Methods:

  • Review of laboratory studies and case reports on residual tumor cell contamination in BMT.
  • Analysis of various ex vivo purging techniques (immunologic and pharmacologic) for tumor cell depletion.

Related Experiment Videos

  • Examination of studies investigating the correlation between purging quality and disease-free survival.

    • Main Results:

    • Laboratory studies confirm persistent residual tumor cells in marrow post-remission.
    • Ex vivo purging techniques can deplete significant logs of tumor cells while preserving hematopoietic stem cells.
    • Emerging evidence suggests a link between effective ex vivo tumor cell elimination and improved disease-free survival.

    Conclusions:

    • Ex vivo marrow purging is a critical area of research for improving outcomes in high-dose therapy and BMT.
    • Further randomized controlled trials are necessary to definitively establish the impact of purged BMT on disease-free survival.
    • Advancements in purging and sensitive detection methods will enhance the understanding and application of this approach.